Sean Essex

Sean Essex has a diverse work experience in the field of scientific research and development. Sean is currently working as the Director - Preformulation and Delivery (Technology Innovation and Development) at Arcturus Therapeutics since October 2022. Prior to this, they worked at Oncorus as an Associate Director from December 2021 to October 2022, and as a Principal Scientist - Synthetic Virus Process Development from April 2021 to December 2021.

Before Oncorus, Sean held positions at Poseida Therapeutics, Inc., where they served as a Senior Scientist (Nanotechnology) from October 2019 to April 2021 and as a Research Scientist - Nanotechnology from September 2018 to October 2019.

Sean'searlier experience includes working as a Scientist III at Thermo Fisher Scientific (Life Technologies) from June 2014 to September 2018, and as an Associate Scientist III at Life Technologies from December 2013 to June 2014.

Sean began their career as a Research Assistant at Northeastern University in 2009 and worked there until 2013. Sean also worked at Northeastern University's Department of Laboratory for Animal Medicine from September 2007 to March 2008.

Overall, Sean Essex has demonstrated a consistent commitment to scientific research and development throughout their career, gaining valuable experience in various roles and organizations within the field.

Sean Essex has a Ph.D. in an unspecified field from Northeastern University, which they obtained in 2013. Prior to their doctoral studies, they earned a master's degree in Pharmaceutical Sciences with a focus on Novel Drug Delivery Systems from Northeastern University. Sean also holds a Bachelor of Pharmacy (B.Pharm.) degree from Bombay College of Pharmacy. The exact years of completion for their master's and bachelor's degrees are unknown.